Granata Bio
PrivateLast Round
Early Funding
May 13, 2025
Total Funding Raised
$29M
Company Overview
Granata Bio is a biopharmaceutical company that develops and commercializes fertility treatments to expand therapeutic choices and enhance access for patients in North America.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Granata Bio Comparables
Compare Granata Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Notify Therapeutics | 79% | |
| Igyxos Biotherapeutics | 78% | |
| Ovo Labs | 77% |
Granata Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 13, 2025 | ||||
| Series A Extension | Jan 15, 2025 | ||||
| Series A | Jan 16, 2024 |
Key People
Founding team and executive leadership
Granata Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A |
| Vibe Bio | Series A |
| Amboy Street Ventures | Series A Extension, Series A |
| Alumni Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 13, 2026
Open roles increased to 5, 2.5x the trailing average.
- May 13, 2025
Completed an early funding round.
Recent news
Latest coverage and updates
- partners_withJun 25, 2026
Granata bio partnered with Gtepartners on Oct 1st '25.
Granata Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Granata Bio's valuation, stock price, and market status.
Is Granata Bio a public or private company?
Granata Bio is a private company.
What is the current stock price of Granata Bio?
Granata Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Granata Bio worth (valuation)?
Valuation information for Granata Bio is not publicly available.
Can I buy Granata Bio stock?
Granata Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Granata Bio's last funding round?
Granata Bio's most recent funding round was Early Funding on May 13, 2025.
Who are the main investors in Granata Bio?
Key investors in Granata Bio include GV.
Will Granata Bio IPO soon?
No public IPO plans have been announced for Granata Bio.
How can I track Granata Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Granata Bio's secondary market activity and sign up for updates.